James S Blachly

James S Blachly

UNVERIFIED PROFILE

Are you James S Blachly?   Register this Author

Register author
James S Blachly

James S Blachly

Publications by authors named "James S Blachly"

Are you James S Blachly?   Register this Author

46Publications

1401Reads

18Profile Views

Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study.

Leuk Lymphoma 2020 Feb 23;61(2):387-396. Epub 2019 Sep 23.

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1665664DOI Listing
February 2020

Transcriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma Progression.

Cancer Res 2019 Nov 4. Epub 2019 Nov 4.

Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, Ohio State University

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-19-1117DOI Listing
November 2019

Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia.

Cancer Discov 2019 Nov 26. Epub 2019 Nov 26.

Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-19-0209DOI Listing
November 2019

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.

N Engl J Med 2018 12 1;379(26):2517-2528. Epub 2018 Dec 1.

From Ohio State University Comprehensive Cancer Center, Columbus (J.A.W., A.S.R., N.A.H., W.Z., K.A.R., G.L., J.S.B., H.G.O., J.C.B.); the Alliance Statistics and Data Center (A.S.R., A.M.B., B.M.-E., B.F., S.J.M.), Mayo Clinic (W.D., S.A.P., M.L.), Rochester, MN; Washington University School of Medicine, St. Louis (N.L.B.); Duke Cancer Institute, Duke University Medical Center, Durham (D.M.B., H.E.), and First Health of the Carolinas Cancer Center, Pinehurst (C.K.) - both in North Carolina; the University of Rochester Medical Center, Rochester, NY (P.M.B.); Stanford University School of Medicine, Stanford (S.C.), and the City of Hope Comprehensive Cancer Center, Duarte (A.H.) - both in California; Dana-Farber Partners CancerCare (J.R.B., R.M.S.) and the Massachusetts General Hospital Cancer Center (J.S.A.) - both in Boston; Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN (S.N.); University of Chicago Comprehensive Cancer Center (R.A.L.) and Loyola University Chicago (S.E.S.) - both in Chicago; the University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada (C.O.); and the Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (R.F.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1812836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325637PMC
December 2018

Case 28-2018: A Man with Epistaxis, Pain and Erythema of the Forearm, and Pancytopenia.

N Engl J Med 2018 12;379(24):2381-2382

Ohio State University, Columbus, OH

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1813964DOI Listing
December 2018

MuCor: mutation aggregation and correlation.

Bioinformatics 2016 05 23;32(10):1557-8. Epub 2016 Jan 23.

Division of Hematology, Department of Internal Medicine, The Ohio State University James Comprehensive Cancer Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btw028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866525PMC
May 2016

Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemia.

Semin Oncol 2016 Apr 8;43(2):265-73. Epub 2016 Feb 8.

Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH; The Ohio State University James Comprehensive Cancer Center, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2016.02.003DOI Listing
April 2016

Chronic Lymphocytic Leukemia: Exploiting Vulnerabilities with Targeted Agents.

Curr Hematol Malig Rep 2016 Feb;11(1):52-60

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-016-0299-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969081PMC
February 2016

Ribosomal revelation.

Authors:
James S Blachly

Blood 2016 Feb;127(8):958-9

THE OHIO STATE UNIVERSITY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-12-688994DOI Listing
February 2016

Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia.

Proc Natl Acad Sci U S A 2015 Apr 18;112(14):4322-7. Epub 2015 Mar 18.

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210; College of Pharmacy, The Ohio State University, Columbus, OH 43210

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1503587112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394264PMC
April 2015

Separating the wheat from the chaff in cHL.

Authors:
James S Blachly

Blood 2015 Feb;125(7):1051-2

THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-12-617555DOI Listing
February 2015

Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib.

J Natl Compr Canc Netw 2015 Jan;13(1):9-13; quiz 13

From the Division of Hematology, Department of Internal Medicine, Department of Pathology, and Division of Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0004DOI Listing
January 2015

PrEMeR-CG: inferring nucleotide level DNA methylation values from MethylCap-seq data.

Bioinformatics 2014 Dec 31;30(24):3567-74. Epub 2014 Aug 31.

College of Medicine, Biomedical Sciences Graduate Program, Department of Internal Medicine, Division of Hematology, Department of Statistics, Mathematical Biosciences Institute, Department of Physics, Department of Chemistry & Biochemistry and Center for RNA Biology, The Ohio State University, Columbus, OH 43210, USA College of Medicine, Biomedical Sciences Graduate Program, Department of Internal Medicine, Division of Hematology, Department of Statistics, Mathematical Biosciences Institute, Department of Physics, Department of Chemistry & Biochemistry and Center for RNA Biology, The Ohio State University, Columbus, OH 43210, USA College of Medicine, Biomedical Sciences Graduate Program, Department of Internal Medicine, Division of Hematology, Department of Statistics, Mathematical Biosciences Institute, Department of Physics, Department of Chemistry & Biochemistry and Center for RNA Biology, The Ohio State University, Columbus, OH 43210, USA College of Medicine, Biomedical Sciences Graduate Program, Department of Internal Medicine, Division of Hematology, Department of Statistics, Mathematical Biosciences Institute, Department of Physics, Department of Chemistry & Biochemistry and Center for RNA Biology, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btu583DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253832PMC
December 2014

Quality Control for RNA-Seq (QuaCRS): An Integrated Quality Control Pipeline.

Cancer Inform 2014 15;13(Suppl 3):7-14. Epub 2014 Oct 15.

Department of Internal Medicine, Division of Hematology, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. ; Shared Genomics Resource, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CIN.S14022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214596PMC
November 2014

Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphoma.

Br J Haematol 2014 Oct 6;167(1):19-32. Epub 2014 Aug 6.

Division of Hematology, Department of Internal Medicine and The Ohio State University James Comprehensive Cancer, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13065DOI Listing
October 2014

Hairy cell leukemia: Update on molecular profiling and therapeutic advances.

Blood Rev 2014 Sep 11;28(5):197-203. Epub 2014 Jul 11.

320 W. 10th Ave, A352 Starling Loving Hall, Columbus, OH 43210, USA; Department of Internal Medicine, Division of Hematology at The Ohio State University, Columbus, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2014.06.003DOI Listing
September 2014